// App-Quantinova.ai

VPB0618 : Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19

Researchers

Presenter

  • C. Eyileten

Principal Investigators

  • Z. Wicik

  • J. Jarosz-Popek

  • M. Wolska

  • K. Klos

  • A. Chcialowski

  • J. Siller-Matula

  • M. Postula

Medical Centers

  • Medical University of Warsaw, Warsaw, Poland

  • Federal Institute of Espírito Santo, Sao Paulo, Sao Paulo, Brazil

  • Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil

  • Istanbul Cerrahpasa University, Istanbul, Istanbul, Turkey

  • medical university of warsaw, warsaw, Mazowieckie, Poland

  • Military Institute of Medicine, warsaw, Mazowieckie, Poland

  • medical university of warsaw, warsaw, Mazowieckie, Poland

  • medical university of vienna, vienna, Wien, Austria

Locations

  • Poland

  • Brazil

  • Turkey

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • miR-16

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved